0

baddrivers

Generic drug preemption ruling a blow to plaintiffs 

  • by
    • July 1, 2013

WASHINGTON – The U.S. Supreme Court’s decision barring state-law design-defect claims against generic drug makers that mirror failure-to-warn actions served a major setback to plaintiffs seeking damages for drug injuries.
The decision in Mutual Pharmaceutical Co. v. Bartlett “struck another blow against granting  recourse for plaintiffs injured by » Continue Reading.
Report […]

Original post by http://lawyersusaonline.com/blog/2013/07/01/generic-drug-preemption-ruling-a-blow-to-plaintiffs/

Report bad drivers!

Related posts:

  1. Justices: Generic drug design-defect claims preempted  WASHINGTON — In a victory to generic pharmaceutical companies, the U.S. Supreme Court ruled today that state design-defect laws that...
  2. Generic drug user can sue brand-name manufacturer  State law allows the user of a generic drug to sue the maker of the name-brand drug for fraudulent misrepresentation,...
  3. Generic drug maker faces liability for out-of-date warning label  Federal law does not preempt a product liability suit alleging that the maker of a generic form of Fosamax failed...
  4. Medicaid preemption ruling nixes one-size-fits-all state liens  WASHINGTON – Several states will have to revisit their Medicaid reimbursement rules after the U.S. Supreme Court struck down a...
  5. Justices to rule on preemption of drug design defect claims  The U.S. Supreme Court has agreed to decide whether federal law preempts state law design defect claims targeting generic pharmaceutical...

Leave a comment